Cargando…
TearCare(®) system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare(®) treatment on subjects with dry eye disease
PURPOSE: Evaluation of the safety and effectiveness of a TearCare(®) retreatment in adult subjects with clinically significant dry eye disease (DED). PATIENTS AND METHODS: This was an extension of an initial 6-month, prospective, single-center, randomized, parallel-group pilot study. In the initial...
Autor principal: | Badawi, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348966/ https://www.ncbi.nlm.nih.gov/pubmed/30774298 http://dx.doi.org/10.2147/OPTH.S191588 |
Ejemplares similares
-
A novel system, TearCare(®), for the treatment of the signs and symptoms of dry eye disease
por: Badawi, David
Publicado: (2018) -
A Comparison of TearCare and Lipiflow Systems in Reducing Dry Eye Disease Symptoms Associated with Meibomian Gland Disease
por: Holland, Edward J, et al.
Publicado: (2022) -
TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled Trial
por: Gupta, Preeya K., et al.
Publicado: (2022) -
A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare(®) System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease
por: Karpecki, Paul, et al.
Publicado: (2020) -
Tear proteomics in dry eye disease
por: Kannan, Ramaraj, et al.
Publicado: (2023)